2025 Guidelines for the Evaluation and Management of Adults With Congenital Heart Disease
December 19, 2025
Brand Name :
Renova, Atralin, Refissa, Retin-A Micro, Retin A, Altreno, Avita
Synonyms :
tretinoin topical
Class :
Topical Acne Agents
Dosage Forms & Strengths
Topical gel
0.025% (Retin-A, Avita)
0.05% (Atralin)
0.1% (Retin-A Micro)
0.01% (Retin-A)
0.04% (Retin-A Micro)
0.08% (Retin-A Micro)
Topical lotion
0.05% (Altreno)
Topical cream
0.025% (Retin-A, Avita)
0.06% (Retin-A Micro Pump)
0.02% (Renova)
0.05% (Renova, Retin-A, Refissa)
0.1% (Retin-A)
Topical solution
0.05% (Retin-A)
Altreno, Avita,Tretin-X, Retin-A, Atralin, Retin-A Micro
Apply a little quantity topically to the skin every night before bed, wherever acne lesions occur. Use enough to cover the whole affected region softly.
Dosage Forms & Strengths
Topical gel
0.025% (Retin-A, Avita)
0.05% (Atralin)
0.1% (Retin-A Micro)
0.01% (Retin-A)
0.04% (Retin-A Micro)
0.08% (Retin-A Micro)
Topical lotion
0.05% (Altreno)
Topical cream
0.025% (Retin-A, Avita)
0.06% (Retin-A Micro Pump)
0.02% (Renova)
0.05% (Renova, Retin-A, Refissa)
0.1% (Retin-A)
Topical solution
0.05% (Retin-A)
<9 years: Safety and efficacy not established (Altreno)
<10 years: Safety and efficacy not established (Atralin)
<12 years: Safety and efficacy not established (Retin-A Micro, Avita, Retin-A)
Apply a little quantity topically to the skin every night before bed, wherever acne lesions occur. Use enough to cover the whole affected region softly.
Refer adult dosing
may increase the therapeutic efficacy of each other when combined
may increase the adverse effect of Retinoic Acid Derivatives
may increase the adverse effect of Multivitamins/Fluoride
may increase the adverse effect of Multivitamins/Fluoride
may increase the adverse effect of Multivitamins/Fluoride
may increase the adverse effect of Multivitamins/Fluoride
may increase the adverse effect of Multivitamins/Fluoride
may increase the photosensitizing effect of Photosensitizing Agents
may increase the photosensitizing effect of Photosensitizing Agents
may increase the photosensitizing effect of Photosensitizing Agents
applying resorcinol with tretinoin topical on the same area may lead to excessive drying and irritation of the skin
Actions and Spectrum:
Mechanism of Action:
Spectrum of Activity:
Frequency not defined
Erythema
Pruritus
Photosensitivity
Edema
Stinging
Scaling
Hyperpigmentation/hypopigmentation
Initial acne flare-up
Blistering
Excessive dryness
Black box warning:
None
Contraindications/caution:
Contraindications:
Caution:
Pregnancy consideration: tretinoin topical is contraindicated during pregnancy. tretinoin can cause congenital disabilities if used during pregnancy.
Pregnancy Category: C
Lactation: The systemic absorption of tretinoin through topical use is low; it can pass into breast milk.
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
The key pharmacological aspects of tretinoin topical:
Pharmacodynamics:
The pharmacodynamic effects of tretinoin topical primarily occur locally at the application site. Its activity is limited to the skin, and systemic effects are generally minimal when used as directed topically.
Pharmacokinetics:
Absorption
tretinoin topical is primarily applied to the skin and acts locally at the application site. It is poorly absorbed through the skin, and the extent of systemic absorption is minimal. The absorption of tretinoin through the skin depends on factors such as the formulation, concentration, integrity of the skin barrier, and the presence of other substances that may enhance or inhibit absorption.
Distribution
After topical application, tretinoin remains localized mainly within the skin and does not extensively distribute throughout the body. The concentration of tretinoin in the skin decreases with increasing depth, and it is primarily found in the upper layers of the epidermis.
Metabolism
tretinoin undergoes metabolism primarily within the skin. It is metabolized by enzymes in the skin, such as cytochrome P450 enzymes, into various metabolites. The specific metabolic pathways of tretinoin in the skin have yet to be fully elucidated. However, it is known that tretinoin can be metabolized to 13-cis-retinoic acid, its isomer, which also exhibits retinoid activity.
Elimination and Excretion
tretinoin and its metabolites are primarily eliminated from the body through desquamation, which is the shedding of dead skin cells. As the skin cells in the upper layers of the epidermis naturally slough off, the tretinoin and its metabolites are eliminated along with them.
Administration:
Patient information leaflet
Generic Name: tretinoin topical
Why do we use tretinoin topical?
tretinoin topical has several uses in dermatology. Here are some typical indications for the use of tretinoin topical: